Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Michael

Showing results (21-30 of 216) with videos related to

Pageof 22
Sort By:
Breast (Edinburgh, Scotland)|December 28, 2010
Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomesMadhu S Singh, Prudence A Francis, Michael Michael
BMJ Case Reports|January 3, 2024
Non-cirrhotic hyperammonaemic encephalopathy secondary to metastatic pancreatic neuroendocrine tumour treated with peptide receptor radio nucleotide therapy and transarterial chemoembolisationZachary Holmes, Hermione Beasley, Mahendra Naidoo, et al.
Expert Opinion on Investigational Drugs|July 12, 2005
Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancerKenneth Khamly, Michael Jefford, Michael Michael, et al.
Expert Opinion on Investigational Drugs|July 28, 2015
An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancerYeh Chen Lee, Michael Michael, John R Zalcberg
Current Opinion in Chemical Biology|August 28, 2020
Natural product discovery through microbial genome miningEmma Kenshole, Marion Herisse, Michael Michael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Adjuvant therapy in gastric cancerLionel Lim, Michael Michael, G Bruce Mann, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 21, 2019
Oxaliplatin versus Mitomycin C following complete cytoreduction for colorectal peritoneal metastases: a comparative studyVignesh Narasimhan, Satish Warrier, Michael Michael, et al.
Annals of Surgical Oncology|April 12, 2022
ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?Michael P Flood, Robert Ramsay, Michael Michael, et al.
The American Journal of Emergency Medicine|August 5, 2003
Patterns of injury in hospitalized terrorist victimsKobi Peleg, Limor Aharonson-Daniel, Michael Michael, et al.
ANZ Journal of Surgery|November 12, 2021
Neoadjuvant therapy in rectal cancer: An ongoing conundrumKasmira Wilson, Michael Michael, Robert Ramsay, et al.
Pageof 22

Showing results (21-30 of 216) with videos related to

Sort By:
Pageof 22
Breast (Edinburgh, Scotland)|December 28, 2010
Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomesMadhu S Singh, Prudence A Francis, Michael Michael
BMJ Case Reports|January 3, 2024
Non-cirrhotic hyperammonaemic encephalopathy secondary to metastatic pancreatic neuroendocrine tumour treated with peptide receptor radio nucleotide therapy and transarterial chemoembolisationZachary Holmes, Hermione Beasley, Mahendra Naidoo, et al.
Expert Opinion on Investigational Drugs|July 12, 2005
Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancerKenneth Khamly, Michael Jefford, Michael Michael, et al.
Expert Opinion on Investigational Drugs|July 28, 2015
An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancerYeh Chen Lee, Michael Michael, John R Zalcberg
Current Opinion in Chemical Biology|August 28, 2020
Natural product discovery through microbial genome miningEmma Kenshole, Marion Herisse, Michael Michael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Adjuvant therapy in gastric cancerLionel Lim, Michael Michael, G Bruce Mann, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 21, 2019
Oxaliplatin versus Mitomycin C following complete cytoreduction for colorectal peritoneal metastases: a comparative studyVignesh Narasimhan, Satish Warrier, Michael Michael, et al.
Annals of Surgical Oncology|April 12, 2022
ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?Michael P Flood, Robert Ramsay, Michael Michael, et al.
The American Journal of Emergency Medicine|August 5, 2003
Patterns of injury in hospitalized terrorist victimsKobi Peleg, Limor Aharonson-Daniel, Michael Michael, et al.
ANZ Journal of Surgery|November 12, 2021
Neoadjuvant therapy in rectal cancer: An ongoing conundrumKasmira Wilson, Michael Michael, Robert Ramsay, et al.
Pageof 22